East Windsor, NJ—Sabinsa has expanded its portfolio of intellectual property with a new patent granted in Mexico, according to a press release. The patent is for a composition of 1-O-galloyl-β-D-glucose (β-glucogallin), isolated from Emblica officinalis (Saberry), and Sabinsa’s Cococin, a concentrate from the liquid endosperm of Cocos nucifera. The composition also contains selenopeptides for protecting the dermal papilla cells.
Dermal papilla cells exist at the bottom of hair follicles, where they play a role in hair formation, growth, and cycling. Maintaining a sufficient number of these cells is essential for hair growth, the press release explains.
Sabinsa’s combination protects the dermal papilla cells from UV induced damage, thereby maintaining them in numbers conducive to hair growth. The patent is supported by a human clinical study published in Clinical, Cosmetic and Investigational Dermatology which showed it to significantly reduce hair fall and thinning.
“Preparations to stimulate hair growth are in high demand, and it’s past time for there to be a natural alternative in this category,” said Dr. Muhammed Majeed, Founder and Chairman of Sabinsa, in the press release. “We’re pleased that the evidence we presented was compelling enough to be granted this latest patent.”
The combination is also patented in Canada, Japan, Russia, Europe, Indonesia, Malaysia, Australia, New Zealand, USA, and Hong Kong.